Adding support to the argument that differential CD32 expression, or at least differences in CD32 signalling activity, may lead to heightened ADRB levels in vivo, are the numerous associations between CD32 polymorphisms and clinical malaria outcome42, 43, 44, 45. Here, FCGR2A is linked to malaria.